Charles Robb
2017
In 2017, Charles Robb earned a total compensation of $1.8M as Chief Financial Officer and Secretary at Corcept Therapeutics.
Compensation breakdown
| Bonus | $320,000 |
|---|---|
| Option Awards | $1,062,589 |
| Salary | $397,929 |
| Total | $1,780,518 |
Robb received $1.1M in option awards, accounting for 60% of the total pay in 2017.
Robb also received $320K in bonus and $397.9K in salary.
Rankings
In 2017, Charles Robb's compensation ranked 6,083rd out of 14,666 executives tracked by ExecPay. In other words, Robb earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,083 out of 14,666 | 59th |
Division Manufacturing | 2,236 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 706 out of 2,075 | 66th |
Industry group Drugs | 544 out of 1,731 | 69th |
Industry Pharmaceutical Preparations | 428 out of 1,333 | 68th |
Source: SEC filing on April 27, 2020.
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2017.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019